使CAR-T.

Min Soo Kim1, Jennifer S Y Ma, Hwayoung Yun

  • 1California Institute for Biomedical Research , 11119 North Torrey Pines Road, Suite 100, La Jolla, California 92037, United States.

概括

一种新的叶酸-FITC分子开关能够精确控制仿真抗原受体 (CAR) -T细胞疗法. 该系统通过向叶酸受体过度表达的瘤来提高安全性,并允许对CAR-T细胞活性进行剂量依赖的调节.